Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$38.0M
-32.7% from 2023
Prescriptions
1.3M
$29.39 per claim
Patients
336K
134,744 prescribers
Total spending, 2024
$38.0M
$113.22 per patient
Medicare prescription drug plans paid $38.0M for Telmisartan in 2024, for 1,292,768 prescriptions and refills to 335,521 patients (down 32.7% from 2023). The average cost per claim was $29.39.
California had the highest Medicare cost for Telmisartan in 2024: $3.8M for 125,852 claims, followed by Texas ($3.5M).
Alexander Fruchter II, internal medicine in Middletown, NY, had the highest Medicare cost for Telmisartan in 2024: 1,216 claims costing $37K.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Alexander Fruchter II Middletown, NY | Internal Medicine | 1,216 | 351 | $37K |
| Cres P Miranda Jr. Las Vegas, NV | Cardiology | 1,200 | 438 | $32K |
| Vicente S Ramo Jr. |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 114,050 | 1,060,285 | 267,206 | $50.5M |
| 2023 | 122,040 | 1,129,197 | 289,659 | $56.4M |
| 2024 | 134,744 | 1,292,768 | 335,521 | $38.0M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Family Practice |
| 810 |
| 246 |
| $27K |
| Curtis A Hamburg Pinecrest, FL | Cardiology | 781 | 240 | $24K |
| Michael K Maxwell Tulsa, OK | Internal Medicine | 427 | 121 | $23K |
| Mark C Houston Nashville, TN | Internal Medicine | 577 | 164 | $23K |
| Harold Hsu Rosemead, CA | Internal Medicine | 1,387 | 191 | $22K |
| Guy L Mintz Great Neck, NY | Cardiology | 719 | 244 | $21K |
| Robert J Koch Libertyville, IL | Cardiology | 649 | 206 | $20K |
| Michael I Dangovian Sterling Hgts, MI | Cardiology | 432 | 130 | $20K |
| Guy N Yatsushiro Honolulu, HI | Internal Medicine | 429 | 130 | $19K |
| Michael N Harris Bend, OR | Internal Medicine | 484 | 136 | $19K |
| Tushar R Modi Modesto, CA | Internal Medicine | 421 | 123 | $18K |
| Joseph I Lee Glendale, CA | Interventional Cardiology | 719 | 196 | $17K |
| Michael C Casciello New Bern, NC | Cardiology | 583 | 152 | $16K |
| Michael P Cecil Covington, GA | Cardiology | 566 | 179 | $16K |
| Anthony Gunawan Houston, TX | Cardiology | 497 | 151 | $16K |
| Roberto Munoz-Marin Santurce, PR | Cardiology | 305 | 90 | $15K |
| Carnie C Nulton Westwood, KS | Internal Medicine | 387 | 110 | $15K |
| Ildefonso Rivera Rivera Bayamon, PR | Cardiology | 329 | 94 | $15K |
| Juan L Garza San Antonio, TX | Cardiology | 606 | 195 | $14K |
| Jeffrey S Matican Englewood, NJ | Cardiology | 407 | 117 | $14K |
| Raju B Raval Fayetteville, NC | Internal Medicine | 584 | 161 | $14K |
| Carl K Yorita Honolulu, HI | Internal Medicine | 241 | 66 | $14K |
| Nabhan Alnabhan Oklahoma City, OK | Interventional Cardiology | 336 | 72 | $14K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Ascend Laborato ALKEM.NS | 435,824 | $12.5M |
| Glenmark Pharma GLENMARK.NS | 313,166 | $9.9M |
| Solco Healthcar | 299,231 | $7.9M |
| Mylan VTRS | 165,954 | $5.5M |
| Micro Labs USA, | 48,294 | $1.3M |
| Zydus Pharmaceu ZYDUSLIFE.NS | 14,133 | $444K |
| Alembic Pharmac | 12,860 | $350K |
| Modavar Pharmac | 2,897 | $81K |
| Avkare | 385 | $12K |
| Aurobindo Pharm AUROPHARMA.NS | 436 | $11K |
| Chartwell Rx Ll | 20 | $547 |